ESTRO 38 - Programme Book & Exhibition Guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

SUNDAY 28 APRIL 2019

10:40 > Stereotactic radiosurgery plus immunotherapy or targeted therapy for brain metastases from NSCLC E. Olmetto (Italy), C. Delli Paoli, L.P. Ciccone, M. Perna, R. Grassi, S. Erika, S. Scoccianti, D. Greto, I. Desideri, G. Simontacchi, L. Marrazzo, C. Arilli, M. Casati, A. Compagnucci, G. Pecchioli, S. Pallotta, L. Livi 10:50 > Interim safety analysis of RAPPORT trial - SABR with pembrolizumab in oligometastatic RCC S. Siva (Australia), M. Bressel, S. Sandhu, B. Tran, J. Mooi, J. Lewin, S. Loi, G. Toner, D. Moon, J. Goad, M. Shaw, S. Chander, T. Eade, A. Guminski, D. Jayamanne, D. Pryor, K. Cuff, S. Wood, N. Lawrentschuk, D. Murphy 11:00 > Radiation-induced lymphopenia: Fractionation effect and association with infections and mortality C. Terrones Campos (Denmark), B. Ledergerber, I. Vogelius, M. Helleberg, L. Specht, J. Lundgren 11:10 > Concurrent and adjuvant effect of bevacizumab on hypofractionated tailor-made IMRT for glioblastomas T. Iuchi (Japan), R. Hara, K. Hatano, T. Sugiyama, G. Togasaki, T. Setoguchi, Y. Hasegawa, M. Itami, T. Sakaida 11:20 > ReRT with bevacizumab is related to lower rate of radionecrosis as reRT alone for recurrent glioma D. Fleischmann (Germany), J. Jenn, S. Corradini, V. Ruf, R. Forbrig, M. Unterrainer, N. Thon, F.W. Kreth, C. Belka, M. Niyazi 11:30 > Phase I/II trial of hafnium oxide nanoparticles activated by SBRT in the treatment of liver cancers E. Chajon (France), M. Pracht, T. De Baere, F. N’Guyen, J. Bronowicki,

OC-0276

OC-0277

OC-0278

OC-0279

OC-0280

V. Vendrely, A. Baumann, V. Croisé-Laurent, E. Rio, Y. Rolland, S. Le Sourd, P. Gustin, C. Perret, F. Mornex, D. Peiffert, P. Merle, E. Deutsch

OC-0281

PROFFERED PAPERS BT 3: Prostate HDR brachytherapy 10:30 - 11:45 | Brown 2 Chair: C. Salembier (Belgium) Chair: J. Van der Voort - van Zyp (The Netherlands)

10:30 > HDR brachytherapy Monotherapy for prostate cancer: a one- day schedule phase II trial acute toxicity

M. Jolicoeur (Canada), T.V. Nguyen, T. Derashodian, E. Hill, M. Mondat, M. Nachabe, E. Antebi, G. Wakil, R. Héliou

OC-0282

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

119